Filing Flows › BioAge Labs (BIOA) › Q2 2025
BioAge Labs (BIOA) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 6, 2025
BioAge Labs (BIOA) reported revenue of $2.4M for the second quarter 2025 (Q2 2025) and +66% from the quarter before.
BioAge Labs, Q2 2025: revenue $2.4M, net loss $21.6M, operating cash flow −$20.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | +66% | — |
| Operating profit | −$24.8M | — | — |
| Net earnings | −$21.6M | — | — |
| Operating cash flow | −$20.0M | — | — |
What changed
Revenue was $2.4M in Q2 2025, up 66% from the previous quarter.
Operating costs exceeded revenue by $24.8M, an operating margin of -1027.0%. The quarter ended with a net loss of $21.6M, wider than the previous quarter's $12.9M loss.
Operating cash flow was −$20.0M. Non-cash charges added back $3.2M of share-based compensation. Working capital and other items used $1.6M. Capital expenditures of $159K exceeded it, leaving free cash flow of −$20.1M.
Questions
What was BioAge Labs' revenue in the second quarter 2025?
BioAge Labs (BIOA) reported revenue of $2.4M for the second quarter 2025 (Q2 2025) and +66% from the quarter before.
Source: BioAge Labs 10-Q on SEC EDGAR.